BioMall
Brand Store/BDB Bioscience/BD IMagTM Anti-Mouse Ly-6G and Ly-6C Particles - DM
BD IMagTM Anti-Mouse Ly-6G and Ly-6C Particles - DM
GENERAL CATALOGUE

BD IMagTM Anti-Mouse Ly-6G and Ly-6C Particles - DM

558111 ·

BDB Bioscience · Cat: 558111

Reach 3+ verified distributors

Catalog No: 558111
Category: reagents
Brand: BDB Bioscience

Description

Positive selection and depletion of mouse Ly-6g and Ly-6C Gr-1 positive lymphocytes. Bone marrow cells were labeled with BD IMag anti-mouse Ly-6G and Ly-6C Gr-1 Particles - DM Cat. No. 558111 as described in the protocol. After labeling, the cells were separated using the BD IMag Cell Separation Magnet Cat. No. 552311 , and the negative Ly-6G and Ly-6g- and positive Ly-6G and Ly-6C+ fractions were collected. Please refer to the Separation Flow Chart to identify the separated cell populations represented in this figure. For flow cytometric analysis, fresh bone marrow left panel , the negative fraction middle panel , and the positive fraction right panel were stained with FITC-conjugated anti-mouse CD11b mAb M1/70 Cat. No. 553310 and PE-conjugated anti-mouse Ly-6G and Ly-6C Gr-1 mAb RB6-8C5 Cat. No. 553128 . The percent Gr-1+ cells in each sample is given. The expected cell recovery ranges from 60 % to 80 %. Positive selection and depletion of mouse Ly-6g and Ly-6C Gr-1 positive lymphocytes. Bone marrow cells were labeled with BD IMag anti-mouse Ly-6G and Ly-6C Gr-1 Particles - DM Cat. No. 558111 as described in the protocol. After labeling, the cells were separated using the BD IMag Cell Separation Magnet Cat. No. 552311 , and the negative Ly-6G and Ly-6g- and positive Ly-6G and Ly-6C+ fractions were collected. Please refer to the Separation Flow Chart to identify the separated cell populations represented in this figure. For flow cytometric analysis, fresh bone marrow left panel , the negative fraction middle panel , and the positive fraction right panel were stained with FITC-conjugated anti-mouse CD11b mAb M1/70 Cat. No. 553310 and PE-conjugated anti-mouse Ly-6G and Ly-6C Gr-1 mAb RB6-8C5 Cat. No. 553128 . The percent Gr-1+ cells in each sample is given. The expected cell recovery ranges from 60 % to 80 %. Show More Positive selection and depletion of mouse Ly-6g and Ly-6C Gr-1 positive lymphocytes. Bone marrow cells were labeled with BD IMag anti-mouse Ly-6G and Ly-6C Gr-1 Particles - DM Cat. No. 558111 as described in the protocol. After labeling, the cells were separated using the BD IMag Cell Separation Magnet Cat. No. 552311 , and the negative Ly-6G and Ly-6g- and positive Ly-6G and Ly-6C+ fractions were collected. Please refer to the Separation Flow Chart to identify the separated cell populations represented in this figure. For flow cytometric analysis, fresh bone marrow left panel , the negative fraction middle panel , and the positive fraction right panel were stained with FITC-conjugated anti-mouse CD11b mAb M1/70 Cat. No. 553310 and PE-conjugated anti-mouse Ly-6G and Ly-6C Gr-1 mAb RB6-8C5 Cat. No. 553128 . The percent Gr-1+ cells in each sample is given. The expected cell recovery ranges from 60 % to 80 %.

More from BDB Bioscience

BD HorizonTM BV421 Mouse Anti-Human TIGIT
BD HorizonTM BV421 Mouse Anti-Human TIGIT
570445
reagents
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
BD OptiBuildTM BV750 Mouse Anti-Human HLA-DQ
746968
reagents
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
BD OptiBuildTM BV750 Rat Anti-Mouse CD93 (Early B Lineage)
746849
reagents
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
BD OptiBuildTM BV510 Rat Anti-Mouse Delta-Like Protein 1
744997
reagents
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
BD OptiBuildTM BUV805 Mouse Anti-Human CD275
748933
reagents
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
BD OptiBuildTM BV650 Rat Anti-Mouse CD23
740456
reagents
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
BD OptiBuildTM R718 Rat Anti-Mouse CCRL2
752021
reagents
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
BD PharmingenTM Mouse B Lymphocyte Activation Antibody Cocktail, with Isotype Control; PE-CyTM7 CD25, PE CD69, & FITC CD19
558064
reagents